ERYTECH to Host on September 22, 2020 Second Quarter 2020 Conference Call and Business Update

ERYTECH Pharma (Euronext Paris: ERYP – Nasdaq: ERYP), a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating therapeutic drug substances inside red blood cells, today announced that it will host its second quarter 2020 conference call and webcast on Tuesday, September 22, 2020, at 2:30 PM CEST/8:30 AM EST to discuss operational highlights.

The call is accessible via the below teleconferencing numbers, followed by the Conference ID#: 8585556#

  • USA/Canada: +1 (833) 818-6807
  • France: +33 1 70 80 71 53
  • United-Kingdom: +44 2031070289
  • International Dial-In Number: +1 (409) 350-3501

The webcast can be followed live online via the link: https://edge.media-server.com/mmc/p/ypvwj59i

An archived replay of the call will be available for 7 days by dialing + 1 855 859 2056, Conference ID: 8585556#.

An archive of the webcast will be available on ERYTECH’s website, under the “Investors” section at http://investors.erytech.com

>> Link to slideshow

ERYTECH to Host on May 7, 2020 First Quarter Conference Call and Business Update

ERYTECH Pharma (Euronext Paris: ERYP – Nasdaq: ERYP), a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating therapeutic drug substances inside red blood cells, today announced that it will host its 2020 first quarter conference call and webcast on Wednesday, May 7, 2020, at 2:30 PM CEST/8:30 AM EST to discuss operational highlights.

The call is accessible via the below teleconferencing numbers, followed by the Conference ID#: 9688486#

  • USA/Canada: +1 (833) 818-6807
  • France: +33 1 70 80 71 53
  • United-Kingdom: +44 2031070289
  • International Dial-In Number: +1 (409) 350-3501

The webcast can be followed live online via the link: https://edge.media-server.com/mmc/p/ub95wf2d

An archived replay of the call will be available for 7 days by dialing + 1 855 859 2056, Conference ID: 9688486#.

An archive of the webcast will be available on ERYTECH’s website, under the “Investors” section at http://investors.erytech.com

>> Link to slideshow

ERYTECH to Host Fourth Quarter and Full Year 2019 Conference Call and Business Update

ERYTECH Pharma (Euronext Paris: ERYP – Nasdaq: ERYP), a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating therapeutic drug substances inside red blood cells, today announced that it will host its fourth quarter and full year 2019 conference call and webcast on Tuesday, March 17, 2020, at 1:30 PM CET/8:30 AM EST to discuss operational highlights.

The call is accessible via the below teleconferencing numbers, followed by the Conference ID#: 1671839#

  • USA/Canada: +1 (833) 818-6807
  • France: +33 1 70 80 71 53
  • United-Kingdom: +44 2031070289
  • International Dial-In Number: +1 (409) 350-3501

The webcast can be followed live online via the link: https://edge.media-server.com/mmc/p/h2zjygca

An archived replay of the call will be available for 7 days by dialing + 1 855 859 2056, Conference ID: 1671839#.

An archive of the webcast will be available on ERYTECH’s website, under the “Investors” section at http://investors.erytech.com.

>> Link to slideshow

Menu